D-0656-2026 Class II Ongoing
FDA drug recall D-0656-2026 was initiated by ACCORD HEALTHCARE, INC. on June 8, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 6432 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- July 8, 2026
- Initiation Date
- June 8, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6432 bottles
Product Description
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.
Reason for Recall
Subpotent Drug
Distribution Pattern
US Nationwide.
Code Information
Lot # D2401522, Exp Date: 06/2026.